Publications

Staskal DF, Diliberto JJ, DeVito MJ, Birnbaum LS. Tissue distribution and elimination of BDE 47 in mice following a single oral dose. Dioxin 2004, Berlin, Germany, September 2004.

Grasty RC, Roberts N, Grey BE, Lau C, Rogers JM. 2004. Perfluorooctane sulfonate (PFOS) alters lung development in the neonatal rat. Birth Defects Res A 70(5)264, Abstract 42; doi: 10.1002/bdra.20026.

Staskal DF, Diliberto JJ, DeVito MJ, Birnbaum LS. Disposition of 2,2’,4,4’-tetrabromodiphenylether (BDE 47) in female mice. Society for Toxicology 43rd Annual Meeting, Baltimore, MD, March 2004.

Grasty RC, Roberts N, Grey BE, Lau C, Rogers JM. Effects of prenatal exposure to perfluorooctane sulfonate on the developing lung in the rat. Society for Toxicology 43rd Annual Meeting, Baltimore, MD, March 2004.

Urban JD, Gay EA, Mailman RB. Decreased neurological side-effects with aripiprazole: A result of functional selectivity of the D2 receptor? Society of Toxicology 43rd Annual Meeting, Baltimore, MD, March 2004.

Perry CS. Process for development of protective concentration levels for remediation sites in Texas. Presented at Society for Environmental Toxicology and Chemistry (SETAC) meeting, Austin, TX, November 2003.

Staskal DF, DeVito MJ, Ross DG, Birnbaum LS. Caffeine, acetanilide, and methoxyresorufin metabolism by rat and human CYP1A2 SUPERSOMES and their inhibition by 2,3,7,8,-tetrachlorodibenzo-p-dioxin (TCDD). Dioxin 2003, Boston, MA, 2003. Organohalogen Compounds 64:324-327.

Grasty RC, Grey BE, Lau CS, Rogers JM. 2003. Window of susceptibility to perfluorooctane sulfonate (PFOS)-induced neonatal mortality in the rat. Birth Defects Research B 68(3):5.

Staskal DF, DeVito MJ, Ross DG, Birnbaum LS. A comparison of the metabolism of methoxyresorufin, acetanilide, and caffeine in rat and human CYP1A2 SUPERSOMES, Society of Toxicology 42nd Annual Meeting, Salt Lake City, UT, 2003.

Perry CS. TRRP Rule – The basics part 2: Human health PCLs and look-up tables. TNRCC Environmental Trade Fair presentation and paper, 2002.